Brain Antigens Stimulate Proliferation of T Lymphocytes With a Pathogenic Phenotype in Multiple Sclerosis Patients

Front Immunol. 2022 Jan 31:13:835763. doi: 10.3389/fimmu.2022.835763. eCollection 2022.

Abstract

A method to stimulate T lymphocytes with a broad range of brain antigens would facilitate identification of the autoantigens for multiple sclerosis and enable definition of the pathogenic mechanisms important for multiple sclerosis. In a previous work, we found that the obvious approach of culturing leukocytes with homogenized brain tissue does not work because the brain homogenate suppresses antigen-specific lymphocyte proliferation. We now report a method that substantially reduces the suppressive activity. We used this non-suppressive brain homogenate to stimulate leukocytes from multiple sclerosis patients and controls. We also stimulated with common viruses for comparison. We measured proliferation, selected the responding CD3+ cells with flow cytometry, and sequenced their transcriptomes for mRNA and T-cell receptor sequences. The mRNA expression suggested that the brain-responding cells from MS patients are potentially pathogenic. The T-cell receptor repertoire of the brain-responding cells was clonal with minimal overlap with virus antigens.

Keywords: T lymphocytes; T-cell receptor; autoantigen; autoimmunity; multiple sclerosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Autoantigens / immunology
  • Brain / immunology*
  • CD4-Positive T-Lymphocytes / physiology*
  • CD8-Positive T-Lymphocytes / physiology*
  • Cell Proliferation
  • Female
  • Flow Cytometry
  • Humans
  • Lymphocyte Activation
  • Male
  • Multiple Sclerosis / blood
  • Multiple Sclerosis / immunology*
  • Phenotype
  • Receptors, Antigen, T-Cell / genetics*
  • Young Adult

Substances

  • Autoantigens
  • Receptors, Antigen, T-Cell